Explore the complete record of transactions filed by 이행명, Président. Director active across 2 companies, notably 명인제약. In total, 17,943 reports have been logged. History available since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Lee Haeng-myung is the Chairman at 명인제약. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. His experience is valuable for the company's future direction.